APD597 is a GPR119 agonist intended for the treatment of type 2 diabetes, with EC50 of 46 nM for hGPR119.
IC50 value: 46 nM (EC50) [1]
Target: hGPR119
The design and synthesis of a second generation GPR119-agonist clinical candidate for the treatment of diabetes is described. APD597 was selected for preclinical development based on a good balance between agonist potency, intrinsic activity and in particular on its good solubility and reduced drug-drug interaction potential. [1]
分子式
C21H29N5O6S
分子量
479.55
CAS号
897732-93-3
运输条件
Room temperature in continental US; may vary elsewhere.